You are here

As biotech selling spreads, more weakness is seen for US health stocks

BT_20151026_KVHEALTH26_1943550.jpg
The cautious attitude of investors is new for the S&P 500 healthcare sector, which has provided double-digit returns every year since 2011.

New York

AFTER a four-year love affair with healthcare shares, investors are moving on.

Selling has spread from biotechs - shaken on Sept 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom